Supplementary Table 9 from Concurrent Pituitary and Thyroid Immune-Related Adverse Events after Immune Checkpoint Inhibitors Associated with HLA-DR15–Related Haplotypes
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Comparison of overall survival of patients with pituitary irAE in the P+T group and P group.
Fields of Study & Subjects
Cancer Immunotherapy and Biomarkers
Pharmacovigilance and Adverse Drug Reactions
Adrenal Hormones and Disorders
Publication details
- Publication date
- 2 April 2026
- Language
- EN